Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate COVID 19 Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04595136
What this trial is testing

Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient

Who this might be right for
SARS-CoV-2 Infection
United Medical Specialties 60
Testing effectiveness (Phase 2)Study completedNCT04419025
What this trial is testing

Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease

Who this might be right for
COVIDSars-CoV2SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere+1 more
Cambridge Health Alliance 165
Testing effectiveness (Phase 2)Study completedNCT04551898
What this trial is testing

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
BeiGene 181
Large-scale testing (Phase 3)UnknownNCT04712279
What this trial is testing

The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial)

Who this might be right for
Covid19
Corpometria Institute 294
Testing effectiveness (Phase 2)UnknownNCT05381519
What this trial is testing

Evaluate the Efficacy and Safety of DXP604 in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Wuhan Institute of Biological Products Co., Ltd 50
Testing effectiveness (Phase 2)Ended earlyNCT04530617
What this trial is testing

Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients

Who this might be right for
Covid19DiabetesHypertension+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 246
Large-scale testing (Phase 3)UnknownNCT04411433
What this trial is testing

Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19

Who this might be right for
Sars-CoV2COVID-19
Ministry of Health, Turkey 1,008
Not applicableWithdrawnNCT04651387
What this trial is testing

Efficacy and Safety of Ozonised Oil (HOO) in COVID-19 Patients

Who this might be right for
SARS-CoV Infection
Neuromed IRCCS
Large-scale testing (Phase 3)Study completedNCT05716425
What this trial is testing

Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)

Who this might be right for
COVID-19
Zhejiang ACEA Pharmaceutical Co. Ltd. 1,218
Large-scale testing (Phase 3)Study completedNCT04602000
What this trial is testing

Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection

Who this might be right for
SARS-CoV-2 Infection
Celltrion 1,642
Testing effectiveness (Phase 2)Study completedNCT06676709
What this trial is testing

Effect of IMMUNEPOTENT-CRP on Serum Pro-Inflammatory Cytokines in Mild to Moderate COVID-19

Who this might be right for
COVID-19SARS-CoV2 Infection
Universidad Autonoma de Nuevo Leon 80
Early research (Phase 1)Ended earlyNCT05429021
What this trial is testing

IMM-BCP-01 in Mild to Moderate COVID-19

Who this might be right for
SARS-CoV2 InfectionCOVID-19
Immunome, Inc. 9
Testing effectiveness (Phase 2)Temporarily pausedNCT04711863
What this trial is testing

Fluvoxamine for Adults With Mild to Moderate COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2Coronavirus InfectionMild to Moderate COVID-19
Asan Medical Center 400
Large-scale testing (Phase 3)Ended earlyNCT04504734
What this trial is testing

Bucillamine in Treatment of Patients With COVID-19

Who this might be right for
Covid19
Revive Therapeutics, Ltd. 713
Testing effectiveness (Phase 2)Study completedNCT06847204
What this trial is testing

EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN LAHORE: A RANDOMIZED CONTROL TRIAL

Who this might be right for
COVID - 19
Zaeema Kanwal 66
Large-scale testing (Phase 3)Ended earlyNCT04523090
What this trial is testing

Catalysing the Containment of COVID-19

Who this might be right for
COVID-19
University of Cape Town 322
Testing effectiveness (Phase 2)UnknownNCT04627584
What this trial is testing

Clinical Trial of MW33 Injection in Patients With COVID-19

Who this might be right for
Covid19
Mabwell (Shanghai) Bioscience Co., Ltd. 150
Early research (Phase 1)WithdrawnNCT05596045
What this trial is testing

Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 in Mild to Moderate COVID-19 Patients

Who this might be right for
SARS CoV 2 Infection
Ascletis Pharmaceuticals Co., Ltd.
Not applicableUnknownNCT04828434
What this trial is testing

Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study

Who this might be right for
DementiaDementia, VascularDementia, Mixed+8 more
University College, London 34
Large-scale testing (Phase 3)Study completedNCT04427501
What this trial is testing

LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness

Who this might be right for
COVID-19
Eli Lilly and Company 3,307
Next Page